289 related articles for article (PubMed ID: 22961755)
1. TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis.
Arshad MI; Piquet-Pellorce C; L'Helgoualc'h A; Rauch M; Patrat-Delon S; Ezan F; Lucas-Clerc C; Nabti S; Lehuen A; Cubero FJ; Girard JP; Trautwein C; Samson M
Hepatology; 2012 Dec; 56(6):2353-62. PubMed ID: 22961755
[TBL] [Abstract][Full Text] [Related]
2. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis.
Arshad MI; Rauch M; L'helgoualc'h A; Julia V; Leite-de-Moraes MC; Lucas-Clerc C; Piquet-Pellorce C; Samson M
Eur J Immunol; 2011 Aug; 41(8):2341-8. PubMed ID: 21557213
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
4. Involvement of TRAIL and its receptors in viral hepatitis.
Mundt B; Kühnel F; Zender L; Paul Y; Tillmann H; Trautwein C; Manns MP; Kubicka S
FASEB J; 2003 Jan; 17(1):94-6. PubMed ID: 12475902
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure.
Kuhla A; Eipel C; Siebert N; Abshagen K; Menger MD; Vollmar B
Apoptosis; 2008 Dec; 13(12):1427-38. PubMed ID: 18946736
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.
Mundt B; Wirth T; Zender L; Waltemathe M; Trautwein C; Manns MP; Kühnel F; Kubicka S
Gut; 2005 Nov; 54(11):1590-6. PubMed ID: 16227360
[TBL] [Abstract][Full Text] [Related]
7. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
Chakass D; Philippe D; Erdual E; Dharancy S; Malapel M; Dubuquoy C; Thuru X; Gay J; Gaveriaux-Ruff C; Dubus P; Mathurin P; Kieffer BL; Desreumaux P; Chamaillard M
Gut; 2007 Jul; 56(7):974-81. PubMed ID: 17299060
[TBL] [Abstract][Full Text] [Related]
8. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice.
Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T
Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
10. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
13. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
14. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.
Hao C; Song JH; Hsi B; Lewis J; Song DK; Petruk KC; Tyrrell DL; Kneteman NM
Cancer Res; 2004 Dec; 64(23):8502-6. PubMed ID: 15574753
[TBL] [Abstract][Full Text] [Related]
15. IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency.
Wahl C; Wegenka UM; Leithäuser F; Schirmbeck R; Reimann J
J Immunol; 2009 Apr; 182(8):4521-8. PubMed ID: 19342625
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
Torisu T; Nakaya M; Watanabe S; Hashimoto M; Yoshida H; Chinen T; Yoshida R; Okamoto F; Hanada T; Torisu K; Takaesu G; Kobayashi T; Yasukawa H; Yoshimura A
Hepatology; 2008 May; 47(5):1644-54. PubMed ID: 18393318
[TBL] [Abstract][Full Text] [Related]
17. NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis.
Zender L; Hütker S; Mundt B; Waltemathe M; Klein C; Trautwein C; Malek NP; Manns MP; Kühnel F; Kubicka S
Hepatology; 2005 Feb; 41(2):280-8. PubMed ID: 15660391
[TBL] [Abstract][Full Text] [Related]
18. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.
Piao X; Komazawa-Sakon S; Nishina T; Koike M; Piao JH; Ehlken H; Kurihara H; Hara M; Van Rooijen N; Schütz G; Ohmuraya M; Uchiyama Y; Yagita H; Okumura K; He YW; Nakano H
Sci Signal; 2012 Dec; 5(255):ra93. PubMed ID: 23250397
[TBL] [Abstract][Full Text] [Related]
19. Critical contribution of liver natural killer T cells to a murine model of hepatitis.
Takeda K; Hayakawa Y; Van Kaer L; Matsuda H; Yagita H; Okumura K
Proc Natl Acad Sci U S A; 2000 May; 97(10):5498-503. PubMed ID: 10792025
[TBL] [Abstract][Full Text] [Related]
20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
